UNH Stock Price Today (October 2026) — UnitedHealth Group Incorporated Analysis & Key Metrics 2026-10-16
UnitedHealth Group Incorporated (UNH) is trading at $401.43, down 1.29% today (as of October 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Healthcare growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $481.72 (20.0% upside).
- Volatility is moderate (25.16% annualized), implying notable price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: steady revenue (0.40% YoY) alongside competitive pressures in the Healthcare Plans space.
UNH Stock Analysis: Key Metrics & Valuation (October 2026)
Concise, actionable data for investors
UnitedHealth Group Incorporated - Historical Price & Volume
- Price
- Volume
- Latest price
Market Cap
Enterprise Value: $406.10B
P/E Ratio
Forward P/E: 17.36
Revenue Growth
Year over Year
Analyst Target
+20.0% upside potential
Key Investor Questions About UNH
What investors need to know before buying
Based on current market data, UNH presents a neutral technical setup with mixed signals fundamentals.
- Technicals say: Neutral (RSI 67.76)
- Fundamentals say: Mixed signals (nuanced financial profile)
UNH's growth trajectory depends on its ability to expand within the Healthcare Plans sector while managing margin pressures.
- Future growth will depend on performance in core Healthcare Plans operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for UNH investors include debt exposure and competitive dynamics in the Healthcare Plans industry.
- $73.33B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Healthcare Plans.
52-Week Trading Range
Over the past year, UNH stock traded between $255.97 and $461.62 and currently trades in the middle of that range. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 25.16% annualized volatility and β=0.42, the stock exhibits low sensitivity to market moves—making UNH suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional ownership with low short interest suggests steadier hands and low immediate risk.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines, coverage and TickZen analysis
Market news
Companies Are Saying No to Tokenized Stocks—and Testing Wall Street’s Crypto Push
From Verizon to UnitedHealth, Corporate America Is Balking at ‘Tokenized’ Stocks
Where Could UnitedHealth's Next Growth Come From?
Stock Market Swings On AI Fears, Tumbling Yields; Taiwan Semi, ASML, JPMorgan In Focus: Weekly Review
Health Care Select Sector SPDR (XLV) Adds Eli Lilly and J&J on Wednesday
Latest TickZen Insights
All insights →No TickZen article on UNH yet. Our newest analysis:
Explore More Analysis for UNH
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Earnings snapshot
No upcoming report date yet
Frequently Asked Questions
Common investor questions about UnitedHealth Group Incorporated
UnitedHealth Group Incorporated (UNH) is currently trading at $401.43. The RSI (14-day) is at 67.8, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $481.72 implies 20.0% upside from current levels. Volatility is moderate at 25.2% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for UnitedHealth Group Incorporated (UNH): The trailing P/E ratio is 24.87, which is in line with broader market averages. The forward P/E is 17.36, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 1.22, near 1.0, suggesting roughly fair value relative to growth. Price-to-Book is 3.53. Price-to-Sales is 0.76. Valuation should be compared to Healthcare Plans industry peers for context, as different sectors trade at different multiples.
Based on 25 analysts covering UNH, the consensus price target is $481.72. This represents a 20.0% upside from the current price of $401.43. The range spans from a low target of $380.00 to a high target of $529.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, UnitedHealth Group Incorporated (UNH) pays a dividend with a current yield of approximately 2.46%. The annualized dividend rate is $2.21 per share. The payout ratio is 57.6%, which is moderate and suggests adequate earnings coverage for the dividend. The most recent ex-dividend date was Sep 14, 2026.
Key risks for UnitedHealth Group Incorporated (UNH) investors include: 1. Moderate volatility (25.2% annualized)—price swings are notable. 2. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 3. Healthcare Plans sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is UnitedHealth Group Incorporated's (UNH) current debt and financial health profile: Total debt stands at $73.33B. The debt-to-equity ratio is 0.69x, which is moderate and generally manageable for most companies. The current ratio is 0.78, which is below 1.0 and may indicate short-term liquidity concerns. The quick ratio is 0.70. The company holds $31.47B in cash and equivalents. Free cash flow is positive at $24.27B, providing a cushion for debt servicing and shareholder returns.